# Prospective Study to Determine the Prevalence of Signs of Central Sensitization in Adults With ASD Without Intellectual Developmental Disorders

> **NCT07495761** · — · RECRUITING · sponsor: **Groupe Hospitalier Mutualiste de Grenoble** · enrollment: 100 (estimated)

## Conditions studied

- Pain Management
- Autism Spectrum Disorder (ASD)

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07495761
- **Lead sponsor:** Groupe Hospitalier Mutualiste de Grenoble
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2026-02-04
- **Primary completion:** 2027-07-29
- **Final completion:** 2027-07-29
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2026-03-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07495761

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07495761, "Prospective Study to Determine the Prevalence of Signs of Central Sensitization in Adults With ASD Without Intellectual Developmental Disorders". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07495761. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*